KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $4.0 million.

  • Adaptive Biotechnologies' Depreciation & Amortization (CF) fell 442.73% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 million, marking a year-over-year decrease of 203.13%. This contributed to the annual value of $19.3 million for FY2024, which is 1338.22% down from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Depreciation & Amortization (CF) stood at $4.0 million, which was down 442.73% from $4.1 million recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Depreciation & Amortization (CF) high stood at $5.7 million for Q4 2024, and its period low was $2.3 million during Q1 2021.
  • For the 5-year period, Adaptive Biotechnologies' Depreciation & Amortization (CF) averaged around $4.4 million, with its median value being $4.7 million (2025).
  • In the last 5 years, Adaptive Biotechnologies' Depreciation & Amortization (CF) skyrocketed by 12843.99% in 2021 and then plummeted by 2209.93% in 2024.
  • Quarter analysis of 5 years shows Adaptive Biotechnologies' Depreciation & Amortization (CF) stood at $4.5 million in 2021, then grew by 8.76% to $4.9 million in 2022, then increased by 2.18% to $5.0 million in 2023, then rose by 15.78% to $5.7 million in 2024, then plummeted by 30.87% to $4.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $4.0 million for Q3 2025, versus $4.1 million for Q2 2025 and $4.7 million for Q1 2025.